International Patent: BOOSTER THERAPY FOR TREATING OR PREVENTING EXACERBATIONS OF PULMONARY HYPERTENSION SYMPTOMS

GENEVA, July 31 -- LIQUIDIA TECHNOLOGIES, INC. filed a patent application (US2026/012324) for “BOOSTER THERAPY FOR TREATING OR PREVENTING EXACERBATIONS OF PULMONARY HYPERTENSION SYMPTOMS”. With publication no. WO/2026/161676, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 11/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....